24小时热门版块排行榜    

查看: 3883  |  回复: 36
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

txyamy

木虫 (小有名气)

[求助] 修稿中加一个作者排在第二可以吗?

RT,杂志影响影子比较低,一个审稿人给接受,另一个是大修。在开始的投稿及后来的修改过程中得到一个朋友的大力帮助,但第一次投稿的时候没报什么希望就没有加上朋友,这次想在修改稿上加朋友为第二作者,需要跟编辑特别说明解释下吗,还是就这样默默的加上去算了?    这样编辑会有意见吗?不会直接给拒了吧?
过来人给指点指点呀~~ 谢谢~~
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

klosexs1987

金虫 (小有名气)

【答案】应助回帖

Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial,
personal or other relationships with other people or organizations within three years of beginning the
submitted work that could inappropriately influence, or be perceived to influence, their work. See
also http://www.elsevier.com/conflictsofinterest.
Examples of potential conflicts of interest include employment, consultancies, stock ownership,
honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis), that it is not
under consideration for publication elsewhere, that its publication is approved by all authors and
tacitly or explicitly by the responsible authorities where the work was carried out, and that,
if accepted, it will not be published elsewhere in the same form, in English or in any other
language, including electronically without the written consent of the copyright-holder. To verify
originality, your article may be checked by the originality detection software iThenticate. See also
http://www.elsevier.com/editors/plagdetect.
Contributors
Each author is required to declare his or her individual contribution to the article: all authors must have
materially participated in the research and/or article preparation, so roles for all authors should be
described. The statement that all authors have approved the final article should be true and included
in the disclosure.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and
design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the
article or revising it critically for important intellectual content, (3) final approval of the version to
be submitted.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of
accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove an author,
or to rearrange the author names, must be sent to the Journal Manager from the corresponding author
of the accepted manuscript and must include: (a) the reason the name should be added or removed,
or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that
they agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed. Requests that are not sent by
the corresponding author will be forwarded by the Journal Manager to the corresponding author, who
must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal
Editors of any such requests and (2) publication of the accepted manuscript in an online issue is
suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange
author names in an article published in an online issue will follow the same policies as noted above
and result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for
more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the
agreement will ensure the widest possible dissemination of information. An e-mail will be sent to
the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing
Agreement' form or a link to the online version of this agreement.
Authors whose articles are published in the International Journal for Parasitology will be asked to
transfer copyright for that article to the Australian Society for Parasitology, Inc. If there are any issues
or conflicts of interest which might prevent the author transferring copyright, they should inform the
Editor when submitting the manuscript.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal
circulation within their institutions. Permission of the Publisher is required for resale or distribution
outside the institution and for all other derivative works, including compilations and translations
(please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are
AUTHOR INFORMATION PACK 14 Jul 2011 www.elsevier.com/locate/ijpharm 6
included, the author(s) must obtain written permission from the copyright owners and credit the
source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred
to: http://www.elsevier.com/authorsrights.
这个是international journal of pharmaceutics的guide of authors,里面就很详细的提过作者变动,以及相关利益关系,LZ可以看看!
24楼2013-01-31 13:49:09
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 37 个回答

wes2100

木虫 (正式写手)

【答案】应助回帖

★ ★
感谢参与,应助指数 +1
txyamy: 金币+2, ★★★很有帮助, 谢谢~ 2013-03-20 00:00:11
添加作者, 最好给编辑通报声, 再附上所有作者的签名函, 函中说明添加的理由.
2楼2013-01-30 21:44:14
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

匿名

用户注销 (著名写手)

★ ★
感谢参与,应助指数 +1
txyamy: 金币+2, ★★★很有帮助, 谢谢~ 2013-03-20 00:00:26
本帖仅楼主可见
3楼2013-01-30 21:46:24
已阅   申请SEPI   回复此楼   编辑   查看我的主页

zuozhijun5134

至尊木虫 (文坛精英)

【答案】应助回帖

★ ★
感谢参与,应助指数 +1
txyamy: 金币+2, ★★★很有帮助, 谢谢~ 2013-03-20 00:00:42
应该可以的,上次就干了一会这事情,呵呵。祝福祝福
4楼2013-01-30 22:08:26
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
信息提示
请填处理意见